Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04226053 · ClinicalTrials.gov registry record · NA

Room to Grow Evaluation for Children

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
322
Enrollment target

NCT04226053: Completed NA study, sponsored by Columbia University.

NCT04226053 is a NA study that has completed, run by Columbia University. The registered enrollment target is 322 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04226053, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
322 participants
Enrollment target

Study Summary

This research project is a small-scale randomized controlled trial (RCT) of an innovative program based in New York City called Room to Grow (RtG). Room to Grow's mission is to enrich the lives of babies born into poverty throughout their critical first three years of development. The research-informed program model combines tailored, one-on-one sessions with an expert clinical social worker in-person every three months plus ongoing communication (via phone and email), provision of essential baby items, and connections to vital community resources. The goal of Room to Grow's innovative program is to help parents increase the probability that their children will enter school ready to learn and continue on to meet their full potential in education, work, and citizenship. The therapeutic, psychodynamic approach and robust three-year long relationship with families is designed to act as the catalyst for sustainable, long-term change in parenting methods and family system stability. Critically, and in contrast to other programs aimed at improving parenting and child development, Room to Grow believes that providing concrete material assistance enhances the effectiveness of counseling and referrals to low-income families by reducing economic stress and freeing up scarce resources.

Primary Outcome

The Center for Epidemiological Studies-Depression (CES-D), is a 20-item measure that asks caregivers to rate how often over the past week they experienced symptoms associated with depression, such as restless sleep, poor appetite, and feeling lonely. Response options range from 0 to 3 for each item (0 = Rarely or None of the Time, 1 = Some or Little of the Time, 2 = Moderately or Much of the time, 3 = Most or Almost All the Time). Scores range from 0 to 60, with high scores indicating greater de

Interventions

  • OTHER Parenting, Child Development

Trial Details

FieldValue
Enrollment Target 322 participants
Start Date 2017-03-31
Est. Completion 2023-10-04
Phase NA
Columbia University

958 total trials

What the finished NCT04226053 record still lists

NCT04226053 is an interventional study that assigns participants to a tested intervention. The registered 322 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).

The record links to 0 conditions, and to 1 intervention - of which Parenting, Child Development is the first listed.

NCT04226053 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04226053 about?

NCT04226053 is a clinical study titled "Room to Grow Evaluation for Children". This research project is a small-scale randomized controlled trial (RCT) of an innovative program based in New York City called Room to Grow (RtG). Room to Grow's mission is to enrich the lives of babies born into poverty throughout their critical first three years of development. The research-infor...

What is the current status of trial NCT04226053?

This trial is currently completed. It is a NA study. The enrollment target is 322 participants. The study started on 2017-03-31. Estimated completion is 2023-10-04.

What interventions are being tested in trial NCT04226053?

The interventions under investigation include: Parenting, Child Development (OTHER).

Who is sponsoring clinical trial NCT04226053?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04226053's enrollment target sits among peer trials

322 315th of 2000 higher than 1,686 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04090359 · 322 participants · Phase 4

    Dual Mobility Acetabular Cups in Revision TJA

  • NCT04924075 · 322 participants · Phase 2

    Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

  • NCT03715933 · 321 participants · Phase 1

    Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • NCT05922878 · 321 participants · Phase 2

    Study of ALTO-300 in MDD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04226053, the US trial registry maintained by the National Library of Medicine. NCT04226053 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.